SciFluor Life Sciences Obtains $30,000,000 New Round

  • Feed Type
  • Date
    4/22/2015
  • Company Name
    SciFluor Life Sciences
  • Mailing Address
    300 Technology Square Cambridge, MA 02139 USA
  • Company Description
    The company’s late-stage fluorination technology is licensed exclusively from Harvard University. SciFluor’s technology enables end-stage or any-stage fluorination of a wide variety of organic compounds. Our technology and our library of fluorinated analogs are protected by an extensive intellectual property portfolio.
  • Website
    http://www.scifluor.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds will be used to accelerate its two lead compounds — one a topical treatment for retinal diseases and the second a treatment for neurological diseases — while expanding its drug discovery and commercialization pipeline.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy